Found "Public health policy": 1,038 results
Sort by
Z - A

Economic evaluation of pegylated interferon plus ribavirin for treatment of chronic hepatitis C in Thailand: genotype 1 and 6

Abstract BACKGROUND: Pegylated interferon alpha 2a, alpha 2b and ribavirin have been included to the National List of Essential Medicines (NLEM) for treatment of only chronic hepatitis C genotypes 2 and 3 in Thailand. This reimbursement policy has not covered for other genotypes of hepatitis

Economic Evaluation of Palliative Management versus Peritoneal Dialysis and Hemodialysis for End-Stage Renal Disease: Evidence for Coverage Decisions in Thailand (2007)

Economic Evaluation of Palliative Management versus Peritoneal Dialysis and Hemodialysis for End-Stage Renal Disease: Evidence for Coverage Decisions in Thailand Yot Teerawattananon1 Miranda Mugford2 Viroj Tangcharoensathien1 1Ministry of Public Health, Nonthaburi, Thailand 2University of E

Economic evaluation of HLA-B*15:02 screening for carbamazepine-induced severe adverse drug reactions in Thailand (2013)

Economic evaluation of HLA-B*15:02 screening for carbamazepine-induced severe adverse drug reactions in Thailand. Waranya Rattanavipapong1, Tanunya Koopitakkajorn1, Naiyana Praditsitthikorn1,2,*, Surakameth Mahasirimongkol3 andYot Teerawattananon1 Summary Purpose There is strong evidence o

Economic evaluation of HLA-B*1502 genotyping in Carbamazepine induced Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN)

Economic evaluation of HLA-B*1502 screening for preventing carbamazepine- induced Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) is prioritized by stakeholders under ‘Research for development of health benefit package under universal coverage scheme’. The study carried out an evidence to inform the Subcommittee for Developm

Economic evaluation of drug treatments in patients with Chronic Hepatitis B (CHB) (in Thai language)

The objective of this study is to determine the economic evaluation of the treatment of chronic hepatitis B by using drugs that are currently available in Thailand, and to analyze the budget impact in listing drugs with cleared health economic evaluation into the National List of Essential Medicines.  01-340-2552

Economic evaluation of an integrated care on delaying chronic kidney disease progression in rural communities of Thailand

In Thailand, the prevalence of chronic kidney disease (CKD) is 17.5% of the population (Ingsathit et al., 2010). According to Thailand’s National Health Security Office (2021), in each year, this public health agency spends approximately 10,000 million Baht in renal dialysis and 1,000 million Baht for the CKD treatment and other related expenses.

Economic evaluation of absorbent products for urinary and fecal incontinence among disabled and elderly people in Thailand (under research for development of health benefit package under universal coverage scheme)

The objective of this study is to determine the economic evaluation of absorbent products for urinary and fecal incontinence among disabled and elderly people in Thailand by taking the monthly average expense of adult diapers, incontinence pads of approximately 2,000 Baht per person into consideration.While a majority of disabled people and depende

Economic Evaluation of 3-Drug Antiretroviral Regimens for the Prevention of Mother-to-Child HIV Transmission in Thailand (2015)

Pitsaphun Werayingyong, BPharm, MSc1, Nittaya Phanuphak, MD2, Kulkunya Chokephaibulkit, MD3, Sripen Tantivess, BPharm, PhD1, Nareeluk Kullert, BSc4, Kakanang Tosanguan, BPharm1, Rukmanee Butchon, MSc1, Nipunporn Voramongkol, MD4, Sarawut Boonsuk, MD5, Songyot Pilasant, BSc1, Wantanee Kulpeng, BSc1,

Economic evaluation and feasibility of PET/CT service in Thailand

เครื่องเพทซีที (Positron emission tomography–computed tomography; PET/CT) เป็นเครื่องมือทางเวชศาสตร์นิวเคลียร์ที่ใช้เทคโนโลยีร่วมกันของเครื่อง PET (Positron Emission Tomography) แล

Economic evaluation and feasibility analysis of using three-drug antiretroviral regimens as the standard regimens for the prevention of mother-to-child transmission of HIV in Thailand (in Thai language)

Zidovudine (AZT) plus single dose nevirapine (AZT+sd-NVP) were provided to pregnant women with HIV infection who have CD4 > 200 cell/mm3 for preventing vertical transmission. However, three-drug regimen is provided to pregnant women with HIV infection regardless CD4 cell count in high resource countries. Mother to child transmission rate in preg
10 / Page